A blueprint for translational regenerative medicine

Area of Science:

• Regenerative Medicine
• Biomedical Engineering
• Translational Science

Background:

• Numerous proof-of-concept studies in regenerative medicine have emerged over recent decades.
• Significant technical and translational obstacles hinder the clinical adoption of promising academic research, often referred to as the "valley of death."

Purpose of the Study:

• To propose a comprehensive blueprint for advancing translational regenerative medicine.
• To provide principles for selecting appropriate cells and biomaterials.
• To outline strategies for navigating the regulatory and manufacturing landscape.

Main Methods:

• Review and synthesis of existing knowledge in regenerative medicine.
• Development of guiding principles for preclinical and clinical translation.
• Identification of key considerations for in vivo imaging and host immune response modulation.
• Analysis of regulatory and manufacturing pathways.

Main Results:

• A strategic framework for translational regenerative medicine is presented.
• Guidelines for optimizing cell and material selection are provided.
• The importance of considering host immune responses throughout development is emphasized.
• A pathway for navigating regulatory and manufacturing processes is suggested.

Conclusions:

• Overcoming the "valley of death" in regenerative medicine requires a structured translational approach.
• Careful consideration of cell/material choice, imaging, immune response, and regulatory factors is crucial for clinical success.
• This blueprint aims to facilitate the transition of regenerative medicine innovations from academic research to clinical application.